Drug Detail
Information about Imatinib + Sunitinib + Regorafenib
Generic Name |
Imatinib + Sunitinib + Regorafenib | |
|---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
KIT Protein Based + Oncogenic Signal Path Based | |
Strategy |
Block KIT + Block related tumor signal paths | |
Drug Category |
KIT/PDGFRA inhibitor | |
This listing created for observational trials of TKI blood levels in GIST
Links |
|
Trials of this drug |
|
|
Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients |
|
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure |
Trial results |
|
Search for this drug/combination in: